BEAM
Beam Therapeutics
Halal Rating :
See Details
Last Price
$23.12
Last updated:
Market Cap
$1.81b
7D Change
8.14%
1 Year Change
-30.51%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Feb. 27, 2024
Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2023 | $316.19m | $233.09m | - | - | 0.00% | 0.00% |
| Sept. 30, 2023 | $17.19m | $163.57m | $12.7m | $12.7m | 73.86% | 7.76% |
| June 30, 2023 | $20.12m | $158.87m | - | $11.95m | 0.00% | 7.52% |
Company Impact
Help us evaluate Beam Therapeutics's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.